Free Trial
NASDAQ:DCGO

DocGo (DCGO) Stock Price, News & Analysis

DocGo logo
$0.56 0.00 (-0.57%)
As of 12:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About DocGo Stock (NASDAQ:DCGO)

Advanced

Key Stats

Today's Range
$0.55
$0.58
50-Day Range
$0.52
$0.74
52-Week Range
$0.49
$1.78
Volume
224,366 shs
Average Volume
878,394 shs
Market Capitalization
$54.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.38
Consensus Rating
Hold

Company Overview

DocGo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

DCGO MarketRank™: 

DocGo scored higher than 59% of companies evaluated by MarketBeat, and ranked 373rd out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DocGo has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    DocGo has a consensus price target of $2.38, representing about 327.2% upside from its current price of $0.56.

  • Amount of Analyst Coverage

    DocGo has only been the subject of 4 research reports in the past 90 days.

  • Read more about DocGo's stock forecast and price target.
  • Earnings Growth

    Earnings for DocGo are expected to grow in the coming year, from ($0.12) to $0.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DocGo is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DocGo is -0.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DocGo has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DocGo's valuation and earnings.
  • Percentage of Shares Shorted

    4.93% of the float of DocGo has been sold short.
  • Short Interest Ratio / Days to Cover

    DocGo has a short interest ratio ("days to cover") of 8.53.
  • Change versus previous month

    Short interest in DocGo has recently decreased by 3.64%, indicating that investor sentiment is improving.
  • Dividend Yield

    DocGo does not currently pay a dividend.

  • Dividend Growth

    DocGo does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for DocGo this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for DCGO on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added DocGo to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DocGo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    3.80% of the stock of DocGo is held by insiders.

  • Percentage Held by Institutions

    56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DocGo's insider trading history.
Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DCGO Stock News Headlines

America's AI Future Needs a Domestic Fuel Chain
AI dominance requires power at a scale most investors have not priced in - and nuclear energy is emerging as a key part of the answer. One NYSE-listed company holds U.S. uranium assets, a North American footprint, and exposure to critical uranium regions. It sits at the intersection of AI power demand, nuclear energy, and America's push for a more secure domestic fuel chain.tc pixel
DocGo Announces First Quarter 2026 Results
See More Headlines

DCGO Stock Analysis - Frequently Asked Questions

DocGo's stock was trading at $0.8778 at the beginning of the year. Since then, DCGO shares have decreased by 36.7% and is now trading at $0.5560.

DocGo Inc. (NASDAQ:DCGO) issued its quarterly earnings results on Monday, May, 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.10. The business earned $75.55 million during the quarter, compared to analysts' expectations of $72.48 million. DocGo had a negative net margin of 62.23% and a negative trailing twelve-month return on equity of 44.09%.
Read the conference call transcript
.

Top institutional investors of DocGo include Renaissance Technologies LLC (1.53%), Isthmus Partners LLC (1.03%) and Dimensional Fund Advisors LP (0.36%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, Anthony Capone, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko.
View institutional ownership trends
.

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
5/11/2026
Today
6/08/2026
Goldman Sachs 47th Annual Global Healthcare Conference 2026
6/08/2026
AGM 2026
6/16/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:DCGO
CIK
1822359
Fax
N/A
Employees
3,568
Year Founded
N/A

Price Target and Rating

High Price Target
$3.00
Low Price Target
$1.00
Potential Upside/Downside
+327.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$182.40 million
Net Margins
-62.23%
Pretax Margin
-62.77%
Return on Equity
-44.09%
Return on Assets
-29.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.79
Quick Ratio
1.79

Sales & Book Value

Annual Sales
$322.20 million
Price / Sales
0.17
Cash Flow
$0.05 per share
Price / Cash Flow
10.11
Book Value
$1.28 per share
Price / Book
0.43

Miscellaneous

Outstanding Shares
98,750,000
Free Float
94,998,000
Market Cap
$54.91 million
Optionable
Optionable
Beta
1.00
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:DCGO) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners